On January 24, 2022, Treatment Action Group (TAG), World Hepatitis Alliance (WHA), Harm Reduction International (HRI), the International Network of People Who Use Drugs (INPUD), and the International Drug Policy Consortium (IDPC) will host a webinar, “Advocating for the Integration of Viral Hepatitis Prevention and Treatment for People Who Use Drugs in PEFPFAR COPs."
This fact sheet on breakthrough COVID-19 infections among people living with HIV was co-produced by TAG and our partners the Black AIDS Institute, Southern AIDS Coalition and the COVID-19 Prevention Network.
This year’s edition of TAGline commemorates TAG’s 30th anniversary, and these articles explore TAG’s work over the years: what we've accomplished, what we've learned, the continuing obstacles to progress, and what comes next.
As public health leaders, researchers, and civil society activists acting in solidarity with communities affected by tuberculosis (TB), we are dismayed by the continued global backslide in progress against history’s oldest pandemic.
With the emergence of MPV and the existing COVID-19 pandemic, there is growing concern amongst communities broadly on what the future holds. On September 29, please join Treatment Action Group, Black AIDS Institute, and the Coronavirus Prevention Network (CoVPN) with special guests Dr. Demetre Daskalakis, Justin James (Twitter: @TheKingOfReads), and Larry Fellows for this free webinar.
On September 14, 2022, a coalition of activists, researchers, and public health professionals sent the following letter to the White House MPX Coordinators, OSTP, CDC, and NIH/NIAID asking for a coordinated and adequately funded comprehensive Federal research effort to contain,…
On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.
Four years after the Medicines Patent Pool (MPP) and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers to ensure commercialization in low- and middle-income countries, generic G/P is not available anywhere.
In 2021, the Global Tuberculosis Community Advisory Board (TB CAB) celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.
On June 2, 2022, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) hosted a Roundtable on Access to Multi-disease Molecular Diagnostics, which brought together country program representatives, donors, members of civil society, and other global health actors to: Identify…